News for Oncothyreon Inc (USA) - Google Finance

Ariad Pharmaceuticals, Inc. (ARIA), Infinity Pharmaceuticals Inc. (INFI ...

Sun, 19 May 2013 16:47:20 GMT

Ariad Pharmaceuticals, Inc. (ARIA), Infinity Pharmaceuticals Inc. (INFI ...
Insider Monkey (blog) - May 19, 2013

Ariad Pharmaceuticals, Inc. As one of the most important conferences in biotechnology approaches (ASCO) we are seeing wild swings of volatility.

Stocks to Watch (Newcastle Investment Corp, Oncothyreon Inc, Infinity ...

Fri, 17 May 2013 14:06:07 GMT

Stocks to Watch (Newcastle Investment Corp, Oncothyreon Inc, Infinity ...
SBWire (press release) - May 17, 2013

Oncothyreon Inc (USA) (NASDAQ:ONTY) shares decreased 24.52% to $1.97. The company on May 16 announced that the presentations of data for L-BLP25 (formerly known as Stimuvax) and PX-866 will take place at the American Society of Clinical ...

Oncothyreon Inc (USA) (NASDAQ:ONTY) down by 24.52%, China Housing ...

Fri, 17 May 2013 13:12:33 GMT

Oncothyreon Inc (USA) (NASDAQ:ONTY) down by 24.52%, China Housing ...
NIS - May 17, 2013

New York, NY - (NISMAGAZINE) - 05/17/2013- Oncothyreon Inc (USA) (NASDAQ:ONTY) on Thursday traded down 24.52% to close at $1.97, with total traded volumes of 5,500 shares in comparison to its average volume of 0.769 million shares.

Oncothyreon Inc (USA) (NASDAQ:ONTY) down by 22.22%, Unilife Corp ...

Thu, 16 May 2013 17:53:25 GMT

Oncothyreon Inc (USA) (NASDAQ:ONTY) down by 22.22%, Unilife Corp ...
NIS - May 16, 2013

New York, NY - (NISMAGAZINE) - 5/16/2013- Oncothyreon Inc (USA) (NASDAQ:ONTY) slipped today by 22.22% to trade currently at $2.03 with a volume of 3.50 million shares.

Stocks Buzz: Exide Technologies, Rexahn Pharmaceuticals, Delcath Systems ...

Tue, 23 Apr 2013 13:19:53 GMT

Stocks Buzz: Exide Technologies, Rexahn Pharmaceuticals, Delcath Systems ...
SBWire (press release) - Apr 23, 2013

Oncothyreon Inc. (USA) (NASDAQ:ONTY) moved up 8.92% and closed at $2.62 on a traded volume of 2.01 million shares. The 52-week range for the stock is $1.71 and $6.24.

Alert: Investors Who Purchased NASDAQ:ONTY Shares in March 2012 Offering ...

Wed, 08 May 2013 12:33:04 GMT

Alert: Investors Who Purchased NASDAQ:ONTY Shares in March 2012 Offering ...
SBWire (press release) - May 8, 2013

On March 28, 2012, Oncothyreon Inc (USA) announced a proposed public offering of common stock and on March 29, 2012, it announced that it has priced the underwritten public offering of 11,750,000 shares of its common stock at a price to the public of ...

Percentage Gainers – Halliburton Company (NYSE:HAL), Oncothyreon Inc (USA ...

Tue, 23 Apr 2013 13:06:06 GMT

Percentage Gainers – Halliburton Company (NYSE:HAL), Oncothyreon Inc (USA ...
Net PR (press release) - Apr 23, 2013

New York, NY - (Net PR News) - 04/23/2013–smartOTCis the premiere destination for Investors and novices alike who wish to receive information on fast moving OTC stocks and undiscovered companies.

NASDAQ:ONTY Stockholder Notice: Investigation of Oncothyreon Inc over ... - Empowered News (press release)
Cytori Therapeutics, Inc. (NASDAQ:CYTX) and Oncothyreon Inc (NASDAQ ... - SBWire (press release)

GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc ...

Mon, 20 May 2013 13:42:00 GMT

GlaxoSmithKline plc (ADR) (GSK), Sanofi SA (ADR) (SNY), Theravance Inc ...
Insider Monkey (blog) - May 20, 2013

Things didn't go nearly as well for Oncothyreon Inc (USA) (NASDAQ:ONTY), which announced the full, and disappointing, results from its unresectable, locally advanced non-small-cell lung cancer drug, L-BLP25.

Percentage Losers – Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Oncothyreon ...

Fri, 17 May 2013 14:15:33 GMT

Percentage Losers – Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Oncothyreon ...
Techsonian (press release) - May 17, 2013

NEW YORK, May 17, 2013 - (Tech Sonian) - FastMovingStock.com is engaged in providing valuable ideas and news information on U.S. stocks on a regular basis. FastMovingStock.com provides detailed research guides on small cap and large cap stocks, ...

Biotech Top Losers, Oncothyreon, Infinity Pharmaceuticals, Cyclacel ...

Fri, 17 May 2013 10:56:01 GMT

Biotech Top Losers, Oncothyreon, Infinity Pharmaceuticals, Cyclacel ...
Crazy Joys - May 17, 2013

Shares of Oncothyreon Inc (USA) (NASDAQ:ONTY) went down on Thursday following a release of disappointing clinical trial data about an experimental lung cancer drug that failed to augment patient survival rate.